Trimetinib

【Product name】Mekinist

[English common name]Trametinib

[Chinese common name]Trimetinib

[English name]

[Chinese other name]

[Indications] MEKINIST is a kinase inhibitor that is detected by an FDA-approved test and is suitable for a single drug or metastasis with BRAF V600E or V600K mutation.MelanomaFor the treatment of patients who cannot be removed.

[Usage and Dosage] Melanoma: MEKINIST confirmed the presence of BRAF V600E or V600K mutation in tumor specimens before starting treatment.
NSCLC: MEKINIST combined with dabrafenib to confirm the presence of BRAF V600E mutation in tumor specimens before starting treatment.
The recommended dosage regimen for MEKINIST is 2 mg orally once a day. Take MEKINIST at least 1 hour before a meal or at least 2 hours after a meal.

[Storage] Refrigerated at 2 ° C to 8 ° C (36 ° F to 46 ° F). Dispense in the original bottle. Do not remove the desiccant. Protect from moisture and light. Do not put the medicine in the kit.

[Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.